{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:38:54Z","timestamp":1785771534475,"version":"3.56.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011710","name":"Shaanxi Provincial Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.lfs.2019.117079","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T12:06:41Z","timestamp":1574165201000},"page":"117079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Activation of PLC\u03b3\/AKT\/I\u03baB\u03b1\/p65 signaling increases inflammation in mast cells to promote growth of cutaneous neurofibroma"],"prefix":"10.1016","volume":"239","author":[{"given":"Jing","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huicong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoguo","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2019.117079_bb0005","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/jid.2014.465","article-title":"Incidence and mortality of neurofibromatosis: a total population study in Finland","volume":"135","author":"Uusitalo","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2019.117079_bb0010","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajpath.2010.10.041","article-title":"The development of cutaneous neurofibromas","volume":"178","author":"Jouhilahti","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2019.117079_bb0015","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000337548","article-title":"Psychological burden in adult neurofibromatosis type 1 patients: impact of disease visibility on body image","volume":"224","author":"Granstrom","year":"2012","journal-title":"Dermatology"},{"key":"10.1016\/j.lfs.2019.117079_bb0020","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI60578","article-title":"MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors","volume":"123","author":"Jessen","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2019.117079_bb0025","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa1605943","article-title":"Activity of selumetinib in neurofibromatosis type 1-related plexiform neurofibromas","volume":"375","author":"Dombi","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2019.117079_bb0030","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.1068452","article-title":"Neurofibromas in NF1: Schwann cell origin and role of tumor environment","volume":"296","author":"Zhu","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.lfs.2019.117079_bb0035","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1172\/JCI99424","article-title":"Contributions of inflammation and tumor microenvironment to neurofibroma tumorigenesis","volume":"128","author":"Liao","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2019.117079_bb0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.celrep.2013.08.033","article-title":"Injury signals cooperate with Nf1 loss to relieve the tumor-suppressive environment of adult peripheral nerve","volume":"5","author":"Ribeiro","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2019.117079_bb0045","first-page":"19","article-title":"Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation","volume":"1796","author":"Maltby","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2019.117079_bb0050","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cell.2008.08.041","article-title":"Nf1-dependent tumors require a microenvironment containing Nf1+\/\u2212- and c-kit-dependent bone marrow","volume":"135","author":"Yang","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2019.117079_bb0055","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S1470-2045(12)70414-X","article-title":"Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial","volume":"13","author":"Robertson","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lfs.2019.117079_bb0060","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/ajmg.a.37045","article-title":"Ketotifen suppression of NF1 neurofibroma growth over 30\u00a0years","volume":"167","author":"Riccardi","year":"2015","journal-title":"Am. J. Med. Genet. A"},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2019.117079_bb0065","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000248467","article-title":"Characterization of mast cells residing in cutaneous neurofibromas","volume":"179","author":"Kamide","year":"1989","journal-title":"Dermatologica"},{"key":"10.1016\/j.lfs.2019.117079_bb0070","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1744-313X.2006.00579.x","article-title":"Serum IgE levels in neurofibromatosis 1","volume":"33","author":"Geller","year":"2006","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.lfs.2019.117079_bb0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000087572","article-title":"Role of mast cell proteases in tissue remodeling","volume":"87","author":"Saito","year":"2005","journal-title":"Chem. Immunol. Allergy"},{"key":"10.1016\/j.lfs.2019.117079_bb0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/mi.2009.136","article-title":"Advances in mast cell biology: new understanding of heterogeneity and function","volume":"3","author":"Moon","year":"2010","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.lfs.2019.117079_bb0085","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/eji.201040559","article-title":"Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity","volume":"40","author":"Galli","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.lfs.2019.117079_bb0090","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0503224102","article-title":"The NF1 tumor suppressor critically regulates TSC2 and mTOR","volume":"102","author":"Johannessen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2019.117079_bb0095","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.2353\/ajpath.2010.100369","article-title":"Nf1\u2212\/\u2212 Schwann cell-conditioned medium modulates mast cell degranulation by c-Kit-mediated hyperactivation of phosphatidylinositol 3-kinase","volume":"177","author":"Chen","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2019.117079_bb0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbadis.2010.12.014","article-title":"Mast cells and inflammation","volume":"1822","author":"Theoharides","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2019.117079_bb0105","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrc3911","article-title":"A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor","volume":"15","author":"Ratner","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2019.117079_bb0110","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00005-006-0049-4","article-title":"Intracellular signaling pathways in IgE-dependent mast cell activation","volume":"54","author":"Kope\u0107","year":"2006","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.lfs.2019.117079_bb0115","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-065X.2008.00742.x","article-title":"The tyrosine kinase network regulating mast cell activation","volume":"228","author":"Gilfillan","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.lfs.2019.117079_bb0120","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s12026-017-8932-0","article-title":"Innate defense regulator IDR-1018 activates human mast cells through G protein-, phospholipase C-, MAPK- and NF-\u03baB-sensitive pathways","volume":"65","author":"Yanashima","year":"2017","journal-title":"Immunol. Res."},{"key":"10.1016\/j.lfs.2019.117079_bb0125","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jbior.2016.09.006","article-title":"Phospholipase C\u03b3 in Toll-like receptor-mediated inflammation and innate immunity","volume":"63","author":"Bae","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.lfs.2019.117079_bb0130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood-2009-09-242875","article-title":"Mast cells and the neurofibroma microenvironment","volume":"116","author":"Staser","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2019.117079_bb0135","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1172\/JCI19195","article-title":"Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+\/\u2212 mast cells","volume":"112","author":"Yang","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2019.117079_bb0140","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2019.117079_bb0145","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2019.117079_bb0150","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2340\/00015555-0938","article-title":"Local mast cell histamine and plasma histamine levels in neurofibromatosis type 1","volume":"90","author":"Yoshida","year":"2010","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.lfs.2019.117079_bb0155","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/978-1-4419-9533-9_14","article-title":"Mast cells, angiogenesis and cancer","volume":"716","author":"Ribatti","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.lfs.2019.117079_bb0160","doi-asserted-by":"crossref","first-page":"43315","DOI":"10.1038\/srep43315","article-title":"An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system","volume":"7","author":"Choi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2019.117079_bb0165","first-page":"996","article-title":"Possible involvement of c-kit receptor and its ligand in increase of mast cells in neurofibroma tissues","volume":"117","author":"Hirota","year":"1993","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.lfs.2019.117079_bb0170","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1182\/blood-2005-06-2271","article-title":"Fc\u03b5R1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells","volume":"107","author":"Qiao","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2019.117079_bb0175","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jaci.2009.08.035","article-title":"Mechanisms of mast cell signaling in anaphylaxis","volume":"124","author":"Metcalfe","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.lfs.2019.117079_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23051145","article-title":"Graminex pollen: phenolic pattern, colorimetric analysis and protective effects in immortalized prostate cells (PC3) and rat prostate challenged with LPS","volume":"23","author":"Locatelli","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2019.117079_bb0185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/bs.apcsb.2016.11.002","article-title":"NF-\u03baB as a therapeutic target in inflammatory-associated bone diseases","volume":"107","author":"Lin","year":"2017","journal-title":"Adv. Protein Chem. Struct. Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2019.117079_bb0190","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0092-8674(02)00703-1","article-title":"Missing pieces in the NF-\u03baB puzzle","volume":"109","author":"Ghosh","year":"2002","journal-title":"Cell"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519310069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519310069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:34:50Z","timestamp":1758400490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320519310069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":38,"alternative-id":["S0024320519310069"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.117079","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of PLC\u03b3\/AKT\/I\u03baB\u03b1\/p65 signaling increases inflammation in mast cells to promote growth of cutaneous neurofibroma","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.117079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117079"}}